A randomized multi-center phase II trial of the angiogenesis inhibitor Cilengitide (EMD 121974) and gemcitabine compared with gemcitabine alone in advanced unresectable pancreatic cancer

BACKGROUND: Anti-angiogenic treatment is believed to have at least cystostatic effects in highly vascularized tumours like pancreatic cancer. In this study, the treatment effects of the angiogenesis inhibitor Cilengitide and gemcitabine were compared with gemcitabine alone in patients with advanced...

詳細記述

保存先:
書誌詳細
主要な著者: Friess, Helmut, Langrehr, Jan M, Oettle, Helmut, Raedle, Jochen, Niedergethmann, Marco, Dittrich, Christian, Hossfeld, Dieter K, Stöger, Herbert, Neyns, Bart, Herzog, Peter, Piedbois, Pascal, Dobrowolski, Frank, Scheithauer, Werner, Hawkins, Robert, Katz, Frieder, Balcke, Peter, Vermorken, Jan, van Belle, Simon, Davidson, Neville, Esteve, Albert Abad, Castellano, Daniel, Kleeff, Jörg, Tempia-Caliera, Adrien A, Kovar, Andreas, Nippgen, Johannes
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2006
主題:
Research Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC1764757/
https://ncbi.nlm.nih.gov/pubmed/17156477
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-6-285
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料